You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
澳優(01717.HK)中期經調整純利升32.1%至5.75億元 研發開支大增72.5%
格隆匯 08-13 20:11

格隆匯8月13日丨澳優(01717.HK)公佈,截至2020年6月30日止6個月,公司收入38.59億元人民幣,同比增長22.6%;毛利20.22億元,同比增長23.4%;公司擁有人應占溢利4.09億元,同比增長56.9%;經調整公司擁有人應占溢利5.75億元,同比增長32.1%;經調整EBITDA 8.29億元,同比增加34.6%;每股盈利25.37分。

作為集團的核心業務分部之一,自家品牌配方奶粉業務表現依然為主要動力,錄得收入達人民幣34.11億元,與2019年中期期間相比增加25.0%,佔集團總收入88.4%(2019年中期期間:86.7%)。

自家品牌配方奶粉收入增長的主要得益於:集團推行有效的戰略計劃,不斷完善業務鏈,持續提高上游營運效益及產品質量;不斷改善產品組合;及堅持擁抱母嬰渠道,以高頻次高質量終端活動賦能渠道,實現品牌方與渠道共生共贏。

期間經營活動的現金流入增加人民幣5.13億元或161.5%。期間集團的毛利率由2019年中期期間的52.1%上升至52.4%,主要是源於利潤較高的自家品牌配方奶粉產品(尤其是海普諾凱荷致(牛奶)等超優質及佳貝艾特悦白(羊奶)等特種分部的產品)的銷售額比例增幅高於其他業務。

公司表示,集團一直最為重視研究及開發。於2020年中期期間,公司研發開支較2019年中期期間高出72.5%。於2020年中期期間,公司成功如期推出兩款全新配方奶粉產品(孕產婦媽媽配方粉及兒童配方粉)及多款全新營養品。再者,集團已與中國知名大學江南大學訂立一份全面戰略合作協議,以鞏固益生菌、羊奶、牛奶蛋白質組學、脂肪組學等多個方面產品開發的研發能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account